To clarify the role of HMGB1 genetic polymorphisms in prostate cancer status, the clinical status and HMGB1 genotype frequencies in 579 prostate cancer patients were assessed (Table 3, Table 4 and Table 5). This evidence concerns the gene HMGB1 and prostate carcinoma.